Denali Therapeutics Inc. (DNLI) market cap

Market cap today
$2.89B

Denali Therapeutics Inc. (DNLI) has a market cap of $2.89B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.85B. That is 15.0% lower than the $3.35B of fiscal 2024. Today's figure is 1.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$2.89B
Market cap, fiscal 2025
$2.85B
Change on fiscal 2024
−15.0%
Growth, 5 years
−21.3% a year
Highest on record
$9.44Bfiscal 2020
Lowest on record
$1.67Bfiscal 2019
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Denali Therapeutics Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 21.3% a year. Across the 8 fiscal year-ends on record (2018–2025), the highest was $9.44B in fiscal 2020 and the lowest $1.67B in fiscal 2019.

History · 8 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Denali Therapeutics Inc. market cap, year by year

Denali Therapeutics Inc. (DNLI) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$2.89B—$18.00—
2025$2.85B 15.0% down$16.51172.65M
2024$3.35B 13.7% up$20.38164.47M
2023$2.95B 15.6% down$21.46137.37M
2022$3.49B 35.6% down$27.81125.53M
2021$5.42B 42.6% down$44.60121.52M
2020$9.44B 466.8% up$83.76112.70M
2019$1.67B 13.0% down$17.4295.61M
2018$1.91B—$20.6692.62M
2017——$15.64—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on DNLI

Denali Therapeutics Inc., figure by figure

Denali Therapeutics Inc. (DNLI) overview: price, valuation and scorecard

Denali Therapeutics Inc. market cap: questions and answers

What is Denali Therapeutics Inc.'s market cap?

Denali Therapeutics Inc. (DNLI) has a market cap of $2.89B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.85B. That is 15.0% lower than the $3.35B of fiscal 2024.

What is the growth rate of Denali Therapeutics Inc.'s market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 21.3% a year.

What are the highest and lowest market cap figures on record for Denali Therapeutics Inc.?

Across the 8 fiscal year-ends on record (2018–2025), the highest was $9.44B in fiscal 2020 and the lowest $1.67B in fiscal 2019.

How is Denali Therapeutics Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Denali Therapeutics Inc. (DNLI) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/DNLI/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.